Generics take center stage in South East Asia

Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The ...

August 21, 2013 | Wednesday | Analysis
China: GSK used sexual bribery to boost sales

Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...

July 15, 2013 | Monday | News
Mayne Pharma acquires generic drugmaker Libertas

Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...

July 5, 2013 | Friday | News
Bribery inquiries rising in China: SPP

Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...

July 15, 2013 | Monday | News
China bans GSK finance head from leaving country

Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...

July 18, 2013 | Thursday | News
UCB sues 15 firms for patent infringement

Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...

July 24, 2013 | Wednesday | News
Deregulation will boost Japanese pharma sector

Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...

June 4, 2013 | Tuesday | News
50% of all drug firms have counter-generics team

Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competit...

August 26, 2013 | Monday | News
Diabetes drug Actos banned in India

Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...

July 10, 2013 | Wednesday | Regulatory
Reports: GSK staff detained in 'fraud data' case in China

Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) ...

July 1, 2013 | Monday | News
Dr Yusuf K Hamied: India's generics king

Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...

March 15, 2012 | Thursday | Influencers
India to realign regulatory with pharma industry

India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, th...

June 6, 2012 | Wednesday | Opinion
Sun Pharma generic testosterone injection gets FDA nod

Mumbai: Sun Pharmaceutical Industries received final approval from the US FDA for its abbreviated new drug application (...

June 6, 2013 | Thursday | Regulatory
GlobalData: New Zealand focuses on generics

Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...

February 27, 2013 | Wednesday | News
Lilly expands partnership with Novast

Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its...

June 13, 2012 | Wednesday | News
Gulf nations woo Indian generic firms

Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Coop...

April 4, 2013 | Thursday | News
Japan's Meiji Seika Pharma buys Medreich

Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. Th...

June 27, 2014 | Friday | News
China cracks the whip on big pharma

Two separate but equally important developments took place in China this month. One, intensification of investigations i...

June 2, 2014 | Monday | Opinion
Mylan to produce generic of Gilead's HIV drug

Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...

August 3, 2012 | Friday | News
Actavis to sell generic AstraZeneca's Crestor

Singapore: US-based Actavis reached a settlement agreement with AstraZeneca resolving outstanding patent litigation rela...

March 26, 2013 | Tuesday | News
Pfizer, GSK sign productivity pact with Singapore's A*Star

Singapore: Pharma industry leaders Pfizer and GlaxoSmithKline have joined hands with global engineering giants Siemens t...

April 24, 2014 | Thursday | News
HIV generics to take over antivirals market

Singapore: Generics are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as ...

July 2, 2012 | Monday | News
Fujifilm, Dr Reddy's terminate generics JV

Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...

June 4, 2013 | Tuesday | News
Dr Reddy's launches generic fracture drug

Hyderabad: Dr Reddy's Laboratories (DRL) launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic vers...

March 7, 2013 | Thursday | News
GSK executives confessed to bribery charges: China

Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...

July 12, 2013 | Friday | News